Head-to-head · Value Score
Gimme Care vs Aurelius Health Group
Two GLP-1 deals, scored on the same six factors. Gimme Care lands a Value Score of 91, Aurelius Health Group a 73. Here's who gives you the honest lower price — and where each one bites back.
Gimme Care
#5 · Grade A · Best Value
Est. first month
$130/mo
Save ~90% vs brand-nameAurelius Health Group
#168 · Grade C+ · Watch List
Est. first month
From $89/mo (compounded)
Save ~93% vs brand-nameThe verdict
Gimme Care takes it on Value Score, 91 to 73 — an est. $130/mo first month, with no teaser step-up baked in. Aurelius Health Group isn't out of it: Shoppers who want transparent, care-inclusive compounded tirzepatide microdosing.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | Gimme Care | Aurelius Health Group |
|---|---|---|
| Value Score | 91 (A) | 73 (C+) |
| Est. first month | $130/mo | From $89/mo (compounded) |
| Save vs brand-name | ~90% | ~93% |
| Semaglutide | $130/mo | Not disclosed |
| Tirzepatide | $163/mo | From $89/mo (compounded) |
| Both molecules | Yes | No |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | Coverage not published |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
Gimme Care
Genuinely cheap on both molecules ($130 / $163) with a LegitScript-certified pharmacy and all-50-state reach.
Why it's a deal
- Low flat price on both molecules ($130 sema / $163 tirz)
- LegitScript-certified pharmacy
- Available in all 50 states
The fine print
- No brand-name option — compounded only
- No oral/sublingual form
Aurelius Health Group
Aurelius Health Group is a telehealth platform built around compounded tirzepatide microdosing — a low-dose dual GIP/GLP-1 protocol rather than standard full-dose therapy — with optional NAD+, L-carnitine,…
Why it's a deal
- Pricing fully published and bundled: $89 first month, then $199/mo all-in — more transparent than most compounded brands
- LegitScript Certified
- Care-inclusive model: consults, monthly monitoring, and secure messaging rather than Rx-only
- Unusually candid about the limited evidence base for microdosing
The fine print
- Microdose-only model — sub-therapeutic doses have thinner trial evidence and likely smaller weight loss than full-dose tirzepatide
- No semaglutide or standard full-dose option
- No named compounding pharmacy partner
- No state list and no named medical director or pharmacist-in-charge
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores Gimme Care is ranked on the Gimme Care alternatives board, and the same list for the other side is on alternatives to Aurelius Health Group.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.